Device labeling symbols on EU-marketed devices need to be accompanied by explanation, exec advises.
This article was originally published in The Gray Sheet
DEVICE LABELING SYMBOLS ON EU-MARKETED DEVICES need to be accompanied by explanatory text, Howard Dobbs, director of international regulatory affairs for Smith & Nephew North America, advised attendees at a June 4 session of the Medical Design and Manufacturing East conference in New York City. Dobbs said that symbols must be explained because the European Commission has not yet harmonized a European Standard for symbols. The issue is particularly problematic in light of the June 14, 1998 implementation date for the EU's Medical Devices Directive (MDD). Compliance with the directive has been optional since January 1995 ("The Gray Sheet" July 17, 1995, p. 20).
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.